Remimazolam for sedation during kidney transplant
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a sedative called remimazolam works well and safely for people getting a kidney transplant. It might help you stay calm and comfortable during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You have chronic kidney failure and are scheduled for a kidney transplant.
- Your BMI (body mass index) is between 18 and 30, and you weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female.
- Your health is classified as ASA III or IV (severe but not life-threatening, or constant threat to life).
- You are not taking sedatives or antidepressants long-term, and you do not have serious liver, heart, lung, or bleeding problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a sedative drug called dexmedetomidine given during kidney transplant surgery to see if it helps protect the new kidney. It might help the kidney work better after the operation.
This study is testing whether the anesthesia drug remimazolam can help protect your kidneys after liver or pancreas surgery. It's comparing it to a standard anesthesia drug to see if it reduces the chances of kidney injury after the operation.
This study tests a sedative called remimazolam to see how well it works and how safe it is for women having gynecologic surgery. It aims to find the best way to keep patients comfortable and stable during the procedure.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests a sedative called remimazolam for people with serious health conditions who need an ERCP, a procedure to examine the bile ducts. It aims to find a safer sedation option for those at higher risk.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
Hear when a new Renal Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.